SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin submits copy of press release

28 Dec 2015 Evaluate

Lupin has submitted a copy of Press Release dated December 28, 2015 titled ‘Lupin Receives FDA Approval for Generic Femhrt Tablets’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2330.00 5.75 (0.25%)
20-Apr-2026 10:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.40
Dr. Reddys Lab 1236.90
Cipla 1236.95
Zydus Lifesciences 942.05
Lupin 2330.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×